Skip to main content
Advertisement
Home
JACC Journals
JACC
JACC: Basic to Translational Science
JACC: Cardiovascular Imaging
JACC: Cardiovascular Interventions
JACC: Heart Failure
Issues
Current
Articles in Press
Archives
Topics
Multimedia
Cardiology Hour
Guidelines
High Blood Pressure Guidelines Hub
VA/SCD Hub
International
Spanish
Go to top of page
Home
JACC Journals
JACC
JACC: Basic to Translational Science
JACC: Cardiovascular Imaging
JACC: Cardiovascular Interventions
JACC: Heart Failure
Issues
Current
Articles in Press
Archives
Topics
Multimedia
Cardiology Hour
Guidelines
High Blood Pressure Guidelines Hub
VA/SCD Hub
International
Spanish
User menu
ACC.org
Guidelines
CME/MOC
About
Login
ACC.org
Guidelines
CME/MOC
About
Login
Source
-- All Journals --
JACC: Basic to Translational Science
JACC: Cardiovascular Imaging
JACC: Cardiovascular Interventions
JACC: Heart Failure
JACC: Clinical Electrophysiology
Journal for the American College of Cardiology
Search for this keyword
Search
ACC.org
Guidelines
CME/MOC
About
Login
Source
-- All Journals --
JACC: Basic to Translational Science
JACC: Cardiovascular Imaging
JACC: Cardiovascular Interventions
JACC: Heart Failure
JACC: Clinical Electrophysiology
Journal of the American College of Cardiology
Search for this keyword
Search
Home
JACC Journals
JACC
JACC: Basic to Translational Science
JACC: Cardiovascular Imaging
JACC: Cardiovascular Interventions
JACC: Heart Failure
Issues
Current
Articles in Press
Archives
Topics
Multimedia
Cardiology Hour
Guidelines
High Blood Pressure Guidelines Hub
VA/SCD Hub
International
Spanish
Multimedia
Figures
Audio
JACC Grand Rounds
ACC Cardiology Hour
Figure1
Restricted access
Filamin C
Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures
Figure 1
Restricted access
Filamin C
Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures
Figure 2
Restricted access
Filamin C
Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures
View table
Table 1
Restricted access
Filamin C
Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures
Figure 3
Restricted access
Filamin C
Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures
Figure 4
Restricted access
Filamin C
Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures
Figure 5
Restricted access
Filamin C
Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures
Figure 6
Restricted access
Filamin C
Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures
Figure 7
Restricted access
Filamin C
Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures
Figure1
Restricted access
The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation
View table
Table 1
Restricted access
The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation
Figure 1
Restricted access
The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation
Figure 2
Restricted access
The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation
Figure 3
Restricted access
The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation
Figure 4
Restricted access
The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation
Figure 5
Restricted access
The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation
Figure 6
Restricted access
The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation
View table
Table 2
Restricted access
The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation
View table
Table 3
Restricted access
The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation
Figure 7
Restricted access
The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation
Pages
1
2
3
4
5
…
next ›
last »
Advertisement
Advertisement